Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Avertto Medical Ltd |
| Country | Israel |
| Start Date | Jul 01, 2022 |
| End Date | Jun 30, 2023 |
| Duration | 364 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 101071850 |
Our vision is to preserve Improve the quality of life by reducing silent stroke impact. We will develop, manufacture, and introduce the first easy-to-use device for alerting stroke for high-risk populations. The first market is hospital use during sedation, with the end-stage market being home telemonitoring.
The company has a clear patentable product, a large growing market, and an expert and experienced team.
StrokeAlert's intellectual property is an alerting system via continuous monitoring of hemodynamic parameters (patent submitted). StrokeAlert's impact will be reducing morbidity and mortality from stroke. We shall compare patients' neurological outcomes with and without StrokeAlert.
Avertto Medical Ltd
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant